College Station, TX and Port Washington, NY – September 25, 2018: G-CON Manufacturing, the leader in prefabricated, prequalified cleanroom solutions, and Pall Corporation, a global leader in filtration, separation and purification, are collaborating to bring turnkey continuous bioprocess or viral vector production facility solutions to the industry. G-CON PODs will be customized with advanced Pall bioprocess equipment, including automation and utility supplies; these will be predesigned into the G-CON cleanroom units for scalable deployment.

“Together, Pall’s cutting-edge technology and G-CON’s flexible cleanroom platform take the concept of modularity one step further, delivering a complete, reproducible, scalable facility solution that is easy to place or relocate, as well as clean, sanitize and even repurpose,” said Mario Philips, Vice President & General Manager at Pall. “This strategic collaboration is particularly important to Pall, as we continuously improve bioprocesses for the industry by offering innovative solutions like G-CON PODs customized with Pall technologies. This solution addresses customer demand for higher efficiencies, while enjoying more flexibility through scale-out and localization of manufacturing.”

PODs from G-CON are mobile, and include integrated process piping and heating and air conditioning (HVAC) systems. Deploying the customized PODs is simple by design, allowing a customer to focus on the target molecule, while relying on the G-CON and Pall teams to optimize the facility design and process. Once designed, the PODs ease verification, qualification and validation challenges by providing comprehensive site acceptance testing and even IQ/OQ support. The PODs’ flexibility allows them to support multiple products, and they can be easily repurposed. In addition, the cost of “building” a facility is drastically reduced, as is build time, which increases the return on investment.

“G-CON’s prefabricated cleanroom units feature a complete, yet compressed footprint for Pall’s continuous bioprocessing and viral vector production designs. The implementation of the Pall processes into our POD infrastructure creates an ideal turnkey solution for our customers. These solutions will be readily deployable and scalable, as they reduce the typical design, verification and qualification efforts by standardizing processes and cleanroom environments,” said Maik Jornitz, President and CEO of G-CON Manufacturing. “We are looking forward to combining our PODs with Pall’s process knowledge and designs to serve our joint customer base. The industry requires optimized, fast, scalable solutions, and these requirements will be met through this collaboration.”

Engineering teams from G-CON and Pall will align to design and deliver the mobile, prefabricated cleanroom units to meet individual customer needs. Process solutions will also be addressed in response to customer needs and applications. Both companies will continue to offer their products and services independently, in addition to the collaboration.

Drawing: Continuous PD Bioprocessing
Drawing: Viral Vector Platform

About G-CON

G-CON Manufacturing designs, produces and installs prefabricated cleanroom PODs®. G-CON’s cleanroom POD portfolio provides a variety of dimensions and serves multiple purposes, from laboratory environments to personalized medicine and production process platforms. POD cleanroom units are unique among traditional cleanroom structures in terms of scalability, mobility and the ability to repurpose the PODs once the production process reaches the end of its lifecycle. For more information, please visit the Company's website at or follow us on social media via LinkedIn, Twitter, YouTube, Instagram and Facebook.

About Pall Corporation

Pall Corporation is a filtration, separation and purification leader, providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide.

For more information visit Or follow us on social media: YouTube - LinkedIn - Twitter - Facebook


For more information:


G-CON Media Contact

Brittany Berryman

Director of Marketing

G-CON Manufacturing, Inc.

6161 Imperial Loop, College Station, TX 77845

Phone: 979-204-7975



Pall Corporate Media Contact

Mariann Kourafas

Director of Communications

Pall Corporation

Phone: +1-508-871-5469


Pall Media Contact

White Matter Communications

Beth Willers


더 Biotech Press Releases
Read all the latest news and developments from Pall and keep in touch with industry trends and opinion.
April 2020
Pall joins a consortium led by Oxford University in fast-tracking clinical trials for a COVID-19 vaccine beginning April 2020.